|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Equity-based compensation expense | |||||
| Deferred income taxes | |||||
| Deferred compensation benefits | |||||
| Loss (gain) on the sale/disposal of property and equipment | |||||
| Impairment of capitalized software | |||||
| Non-taxable life insurance gain | |||||
| Changes in assets and liabilities that provide (use) cash, excluding the effects of acquisitions: | |||||
| Accounts receivable | |||||
| Prepaid and other current assets | |||||
| Other long-term assets | |||||
| Cash surrender value of life insurance | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Income taxes payable / receivable | |||||
| Deferred payroll taxes | |||||
| Advance billings on contracts | |||||
| Other current liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flow from investing activities: | |||||
| Cash paid for acquisitions, net of cash received | |||||
| Additions to property and equipment | |||||
| Additions to capitalized software | |||||
| Proceeds from the sale of property and equipment | |||||
| Premiums paid for life insurance | |||||
| Proceeds from life insurance | |||||
| Net cash used in investing activities | |||||
| Cash flow from financing activities: | |||||
| Proceeds from long-term debt | |||||
| Payments on long-term debt | |||||
| Deferred debt financing costs | |||||
| Proceeds from stock option plan exercises | |||||
| Taxes remitted for shares withheld from equity-based compensation transactions | |||||
| Proceeds from Employee Stock Purchase Plan | |||||
| Change in cash overdraft, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Cash Flow Elements | |||||
| Acquisition share issuance | |||||
| Acquisition stock option issuance | |||||
Loading...